Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 May 17;20(1):235.
doi: 10.1186/s13023-025-03773-6.

Endocrine manifestations and long-term outcomes of patients with mitochondrial diseases

Ja Hye Kim  1 , Dohyung Kim  1 , Soojin Hwang  1 , Gu-Hwan Kim  2 , Beom Hee Lee  1   2 , Han-Wook Yoo #  3 , Jin-Ho Choi #  4
Affiliations

Endocrine manifestations and long-term outcomes of patients with mitochondrial diseases

Ja Hye Kim et al. Orphanet J Rare Dis. .

Abstract

Background: Endocrine dysfunctions are commonly associated with mitochondrial diseases. This study aimed to investigate clinical characteristics and outcomes of endocrine manifestations in patients with mitochondrial diseases.

Methods: This study included 54 patients from 47 families with mitochondrial diseases who were genetically confirmed; 49 patients with mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes (MELAS), four with Pearson syndrome, and one with Kearns-Sayre syndrome (KSS). Clinical and endocrine findings were retrospectively reviewed.

Results: The median age at diagnosis was 18.5 years (range, 0.1 - 49 years). In 49 patients with MELAS, the mean height and weight standard deviation scores were - 2.0 ± 1.3 and - 2.6 ± 1.6, respectively, with 44.9% (n = 22) of the patients exhibiting short stature at diagnosis. Twenty-three (46.9%) patients with MELAS were diagnosed with diabetes mellitus (DM) at a median age of 26 years (range, 12 - 50 years). Interestingly, papillary thyroid cancer was observed in 10.2% of patients (n = 5) with MELAS at a mean age of 34.1 ± 6.9 years. One patient with MELAS and one with KSS exhibited hypoparathyroidism. Patients with Pearson syndrome and KSS exhibited more severe short stature. Adrenal insufficiency was noted in 50% of the patients with Pearson syndrome.

Conclusions: In 20% of patients with MELAS, endocrine dysfunctions including having a short stature, DM, and hypoparathyroidism preceded the onset of neurological manifestations. Papillary thyroid cancer occurred in 10% of patients with MELAS. Patients with Pearson syndrome and KSS showed profound growth retardation and multisystem dysfunctions, such as chronic kidney disease and neurological defects, which contributed to increased mortality.

Keywords: Adrenal insufficiency; Diabetes mellitus; Hypoparathyroidism; Kearns–Sayre syndrome; Mitochondrial encephalomyopathy, lactic acidosis, stroke-like episodes; Pearson syndrome.

PubMed Disclaimer

Conflict of interest statement

Declarations. Ethics approval and consent to participate: This study was approved by the Institutional Review Board of the Asan Medical Center, Seoul, Korea (IRB No. 2024 − 0271). Consent for publication: All authors agreed to publish the manuscript. Competing interests: The authors declare that they have no completing interests.

Figures

Fig. 1
Fig. 1
Trajectories of height SDS in patients with juvenile-onset MELAS
Fig. 2
Fig. 2
The Kaplan-Meier cumulative incidence curve for the time to diagnosis of diabetes in MELAS patients with the m.3243 A > G mutation
See this image and copyright information in PMC

References

    1. Schaefer AM, Walker M, Turnbull DM, Taylor RW. Endocrine disorders in mitochondrial disease. Mol Cell Endocrinol. 2013;379:2–11. - DOI - PMC - PubMed
    1. Ng YS, Turnbull DM. Mitochondrial disease: genetics and management. J Neurol. 2016;263:179–91. - DOI - PMC - PubMed
    1. Chow J, Rahman J, Achermann JC, Dattani MT, Rahman S. Mitochondrial disease and endocrine dysfunction. Nat Rev Endocrinol. 2017;13:92–104. - DOI - PubMed
    1. Logan DC. The mitochondrial compartment. J Exp Bot. 2006;57:1225–43. - DOI - PubMed
    1. Al-Gadi IS, Haas RH, Falk MJ, Goldstein A, McCormack SE. Endocrine disorders in primary mitochondrial disease. J Endocr Soc. 2018;2:361–73. - DOI - PMC - PubMed

LinkOut - more resources